WO2015137024A1 - 処置デバイス及び処置システム - Google Patents
処置デバイス及び処置システム Download PDFInfo
- Publication number
- WO2015137024A1 WO2015137024A1 PCT/JP2015/053269 JP2015053269W WO2015137024A1 WO 2015137024 A1 WO2015137024 A1 WO 2015137024A1 JP 2015053269 W JP2015053269 W JP 2015053269W WO 2015137024 A1 WO2015137024 A1 WO 2015137024A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- energy
- emitters
- state
- tissue
- linear member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC12C3C1C3CC(*)C2 Chemical compound CC12C3C1C3CC(*)C2 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00026—Conductivity or impedance, e.g. of tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00619—Welding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1435—Spiral
Definitions
- the present invention relates to a treatment device and a treatment system for treating a treatment target of a living tissue using thermal energy.
- joining techniques for joining living tissues are required.
- joining techniques for joining tissues include a surgical suturing technique and a mechanical anastomosis technique.
- a treatment tool that joins tissues to be treated using thermal energy (high-frequency energy) is known.
- the treatment tool disclosed in International Publication No. 2011/083027 has a stronger bonding force at an earlier stage when bonding tissues to each other than the bonding between biological tissues using a surgical suture technique or a mechanical anastomosis technique. Obtainable.
- the treatment tool disclosed in International Publication No. 2011/083027 has high-frequency electrodes facing each other. It is difficult to insert such a high-frequency electrode into the channel of the endoscope. For this reason, when joining tissue, the treatment device which can obtain strong joining force at an early stage with minimal invasiveness is desired.
- An object of the present invention is to provide a treatment device and a treatment system capable of joining tissues with a simple procedure while maintaining a minimally invasive state.
- a treatment device is capable of deforming between a substantially straight state and a tissue sandwiching state, and a linear member capable of sandwiching a treatment target in a state deformed to the tissue sandwiching state;
- a first energy release unit disposed at a position where the treatment target is sandwiched in a state where the linear member is disposed in the linear member and is deformed into the tissue sandwiching state; and the first energy release unit
- the linear member is disposed at a position where the treatment target is clamped in cooperation with the first energy release unit in a state where the linear member is deformed to the tissue clamping state and is disposed in the tissue clamping state.
- a second energy emitting unit for treating the treatment target by emitting energy between the first energy emitting unit and the first energy emitting unit.
- the present invention it is possible to provide a treatment device and a treatment system capable of joining tissues with a simple technique while maintaining a minimally invasive state.
- FIG. 1 is a schematic view showing a treatment system according to the first to third embodiments.
- FIG. 2 shows a tissue clamping part (coil part) of a linear member of the treatment device of the treatment system according to the first embodiment, and energy is released between energy emitters facing each other along the central axis of the tissue clamping part. It is a schematic perspective view which shows a mode that it is performed.
- FIG. 3 is a schematic longitudinal sectional view showing a state in which the tissue sandwiching portion and the pusher portion of the linear member of the treatment device of the treatment system according to the first to third embodiments are accommodated in the applicator.
- FIG. 4 shows a case where a living tissue is punctured and penetrated by the puncture portion of the applicator of the treatment device of the treatment system according to the first to third embodiments, and then the distal end side coil body of the tissue clamping portion of the linear member is applied to the applicator.
- FIG. 5 shows a state in which the puncture portion of the applicator is pulled out after the distal end side coil body of the tissue clamping portion of the linear member of the treatment device of the treatment system according to the first to third embodiments is deformed into a coil state.
- FIG. 6 shows a state in which the proximal end side coil body of the tissue clamping portion of the linear member of the treatment device of the treatment system according to the first to third embodiments is protruded from the distal end of the applicator and deformed into a coil state.
- FIG. 7 shows the emitter in a state where the tissue to be treated is sandwiched between the distal coil and the proximal coil of the tissue clamping part of the linear member of the treatment device of the treatment system according to the first to third embodiments.
- FIG. 8 shows the tissue sandwiching portion of the linear member of the treatment device of the treatment system according to the first embodiment, and energy is released between the energy emitters facing each other so as to intersect the central axis of the tissue sandwiching portion.
- FIG. FIG. 9 shows the emitter in a state where the tissue to be treated is sandwiched between the distal side coil and the proximal side coil of the tissue clamping part of the linear member of the treatment device of the treatment system according to the first to third embodiments. It is a schematic longitudinal cross-sectional view which shows the state which cut
- FIG. 10 is a schematic diagram showing the arrangement state of a plurality of first and second energy emitters arranged in the tissue clamping part of the linear member of the treatment device of the treatment system according to the second embodiment.
- FIG. 11 is a schematic diagram showing the arrangement state of a plurality of first and second energy emitters arranged in the tissue clamping part of the linear member of the treatment device of the treatment system according to the third embodiment.
- the biological tissue treatment system 10 is preferably used with an endoscope (not shown).
- the treatment system 10 includes a living tissue treatment device 12 and a controller (energy source) 14 that controls to supply appropriate energy to first and second energy emitting units 24 and 26 described later of the treatment device 12.
- a foot switch 16 is connected to the controller 14.
- the foot switch 16 has first and second pedals 16a and 16b. When the first pedal 16a is operated, a treatment in a joining mode (first mode) for joining the first tissue L1 and the second tissue L2 is performed as described below as an example.
- a treatment in a hole formation mode (second mode) in which holes are formed in the first tissue L1 and the second tissue L2 is performed.
- a hand switch is used together with the foot switch 16 or instead of the foot switch 16.
- a press switch or the like corresponding to the first and second pedals 16a and 16b is disposed on the applicator 28 described later.
- the treatment device 12 is formed as a disposable type. Note that the applicator 28 described later may be reused after being washed, disinfected, and sterilized.
- the treatment device 12 includes a linear member 22 and first and second energy emitting portions 24 and 26.
- the treatment device 12 includes an applicator (guide tool) 28 that guides the linear member 22 and the first and second energy emitting portions 24 and 26 to a treatment target.
- the linear member 22, the first and second energy emitting portions 24 and 26, and the applicator 28 of the treatment device 12 can be used by being inserted into a channel of an endoscope (not shown), and will be described later. It is preferable to be used by being inserted into a channel.
- the applicator 28 is preferably formed of a resin material having electrical insulation, for example.
- the linear member 22 includes, for example, a coil-shaped tissue sandwiching portion 32 and a pusher portion 34 that can move the sandwiching portion 32 forward and backward along the longitudinal direction with respect to the tip of the applicator 28 (a puncture portion 84 to be described later). And have. It is preferable that the clamping part 32 and the pusher part 34 are formed integrally. In addition, the pusher part 34 may be formed with the same raw material as the clamping part 32, and may be formed with another raw material.
- the pinching portion 32 of the linear member 22 can be deformed between a substantially straight state and a tissue pinching state such as a coiled state having a spring property, and can clamp a treatment target in a state of being deformed into the tissue pinching state. Is possible.
- a tissue clamping state such as a coiled state
- the clamping part 32 only needs to exist about several centimeters along the central axis C from the distal end to the proximal end. In a state in which the linear member 22 is deformed to hold the tissue, it is difficult to enter the tubular body 82 described later of the applicator 28, and it is difficult to enter the channel of the endoscope.
- the pinching portion 32 of the linear member 22 is preferably formed of a shape memory alloy material such as a nickel titanium alloy.
- the sandwiching portion 32 of the linear member 22 is transformed from a substantially straight state into a coiled tissue sandwiching state having a spring property.
- the linear member 22 made of a shape memory alloy material maintains a substantially straight state at a temperature lower than the body cavity temperature (for example, room temperature) such as body temperature, and deforms into a tissue sandwiched state at body temperature. Can be formed.
- a heater is disposed on the linear member 22 or the puncture portion 84, which will be described later, of the applicator 28. Heat may be applied to the member 22 to deform it from a substantially straight state to a tissue sandwiching state. Of course, it is also preferable that the linear member 22 can be deformed between a substantially straight state and a tissue clamping state (coiled state) by elastic deformation.
- the linear member 22 will be described as being formed of a shape memory alloy material.
- the clamping part 32 has a distal end side coil body (first coil) 32a and a proximal end side coil body (second coil) 32b disposed on the proximal end side of the distal end side coil body 32a.
- first coil first coil
- second coil proximal end side coil body
- the first and second energy release portions 24 and 26 are disposed in the pinching portion 32 of the linear member 22, respectively. Specifically, the first energy release portion 24 is disposed in the distal end side coil body 32a, and the second energy release portion 26 is disposed in the proximal end side coil body 32b. For this reason, the 1st and 2nd energy discharge
- the first energy release portion 24 faces the second energy release portion 26 in a state where the holding portion 32 of the linear member 22 is deformed into the tissue holding state.
- release part 24 is arrange
- the second energy release portion 26 is disposed at a position where the treatment target is held in cooperation with the first energy release portion 24 in a state where the holding portion 32 of the linear member 22 is deformed into the tissue holding state. Is done. And the 2nd energy discharge
- the first energy emitting unit 24 includes a plurality of energy emitting bodies 44a, 44b, 44c, and 44d (hereinafter, mainly denoted by reference numeral 44) (here, four examples will be described).
- Each discharge body 44 is separated along the longitudinal direction L of the linear member 22 in a state in which the sandwiching portion 32 is substantially straight.
- the respective emitters 44 are separated at appropriate intervals along the winding direction L when the distal end side coil body 32a of the sandwiching portion 32 is in the tissue sandwiching state (coiled state).
- the energy emitters 44 are electrically insulated from each other.
- a high frequency electrode, a heater, etc. can be used, for example, and heat energy can be added to the treatment target.
- the second energy emitting unit 26 has a plurality (here, four examples will be described) of energy emitting bodies 46a, 46b, 46c, 46d (hereinafter, mainly denoted by reference numeral 46).
- Each emitter 46 is separated along the longitudinal direction L of the linear member 22 in a state in which the sandwiching portion 32 is substantially straight. In other words, the respective emitters 46 are separated at appropriate intervals along the winding direction L when the proximal end side coil body 32b of the sandwiching portion 32 is in the tissue sandwiching state (coiled state).
- the energy emitters 46 are electrically insulated from each other.
- a high-frequency electrode, a heater, or the like can be used, and heat energy can be added to the treatment target.
- a high-frequency electrode is used as the energy emitter 46 will be described.
- the shape of the clamping portion 32 of the linear member 22 is stored.
- the emitters 44 and 46 that are opposed or substantially opposed to each other among the first and second energy emitting portions 24 and 26 are determined.
- the emitters 44a and 46a face each other
- the emitters 44b and 46b face each other
- the emitters 44c and 46c face each other
- the emitters 44d and 46d face each other. opposite.
- the emitters 44a and 46a, the emitters 44b and 46b, the emitters 44c and 46c, and the emitters 44d and 46d are arranged on the central axis C in the tissue clamping state when the linear member 22 is deformed to the tissue clamping state. It is arranged to face the position along.
- the controller 14 controls a switching unit 74 described later, and the plurality of emitters 44 of the first energy release unit 24 and the second energy release unit 26 are controlled. Energy E1 can be applied between the more proximal emitters 44, 46 with the plurality of emitters 46.
- the emitters 44 and 46 are opposed to a state (including a substantially intersecting state) intersecting the central axis C in the tissue sandwiching state with respect to each other in a state where the linear member 22 is deformed to the tissue sandwiching state. It is preferable that they are arranged. As shown in FIG. 8, the emitters 44a and 46c face the position intersecting the central axis C, the emitters 44b and 46d face the position intersecting the central axis C, and the emitters 44c and 46a are center axis C. , And the emitters 44d and 46b face the position where the central axis C intersects.
- the controller 14 controls a switching unit 74 described later, and the plurality of emitters 44 of the first energy release unit 24 and the second energy release.
- Energy E ⁇ b> 2 can be applied between the more distal emitters 44, 46 of the section 26 with the plurality of emitters 46.
- the linear member 22 is preferably formed in a tubular shape.
- conductive wires 54 a, 54 b, 54 c, 54 d (hereinafter, mainly denoted by reference numeral 54) electrically connected to the first energy emitter 44 and the second energy emitter 46 are electrically connected.
- Conductive wires 56a, 56b, 56c, and 56d (hereinafter, mainly denoted by reference numeral 56) are disposed. That is, the conductor 54a is electrically connected to the emitter 44a, the conductor 54b is electrically connected to the emitter 44b, the conductor 54c is electrically connected to the emitter 44c, and the conductor 54d is electrically connected to the emitter 44d.
- the conductor 56a is electrically connected to the emitter 46a
- the conductor 56b is electrically connected to the emitter 46b
- the conductor 56c is electrically connected to the emitter 46c
- the conductor 56d is connected to the emitter 46d. Electrically connected.
- Each of the conductive wires 54 and 56 can be attached to and detached from a controller 14 having an energy source 72 described later by a connector 58.
- the controller 14 has an energy source 72 capable of supplying appropriate energy to the first and second energy emitting units 24 and 26 of the treatment device 12. For this reason, the energy output of the energy source 72 is controlled by the controller 14. That is, the energy output amount, energy output time, and the like of the energy source 72 are appropriately controlled by the controller 14.
- the energy source 72 is electrically connected to each emitter 44 of the first energy emitting unit 24 by each conductor 54 and electrically connected to each emitter 46 of the second energy emitting unit 26 by each conductor 56. Has been. Therefore, energy can be transmitted from the energy source 72 to the emitters 44 and 46 through the conductors 54 and 56.
- the energy source 72 in the treatment using high frequency energy often has a limited current capacity. Therefore, the energy source 72 is connected to at least one of the emitters 44 of the first energy emitting unit 24 and at least one of the emitters 46 of the second energy emitting unit 26 according to the current capacity. It is preferable that energy can be supplied. Therefore, as shown in FIG. 1, the controller 14 preferably includes a switching unit 74 that switches the output state in preparation for a case where the current capacity is limited.
- the switching unit 74 selects one or more of the plurality of emitters 44 a, 44 b, 44 c, 44 d of the first energy emitting unit 24, that is, the conducting wires 54 a, 54 b, 54 c, 54 d, and the plurality of second energy emitting units 26 Are controlled by the controller 14 to select one or more of the emitters 46a, 46b, 46c, 46d, ie, the conductors 56a, 56b, 56c, 56d.
- energy can be transmitted from the energy source 72 of the controller 14 to the appropriate energy emitters 44 and 46 among the plurality of energy emitters 44 and 46 through the conductors 54 and 56, respectively. If the current capacity of the energy source 72 is not limited, it is preferable to simultaneously output energy to a plurality of pairs of emitters 44a, 44b, 44c, 44d, 46a, 46b, 46c, 46d at the same time.
- the switching unit 74 is controlled by the controller 14 to first supply appropriate energy between the emitters 44a and 46a, and then stops supplying energy. Next, after supplying appropriate energy between the emitters 44b and 46b, the supply of energy is stopped. Subsequently, after supplying appropriate energy between the emitters 44c and 46c, the supply of energy is stopped. Finally, after supplying appropriate energy between the emitters 44d and 46d, the supply of energy is stopped.
- the switching unit 74 is controlled to supply energy substantially continuously to the living tissue. That is, the controller 14 controls to start supplying energy to the tissue between the emitters 44b and 46b, for example, simultaneously or substantially simultaneously with stopping the supply of energy to the tissue between the emitters 44a and 46a. be able to.
- the emitters 44 and 46 can be used as sensors for detecting biological information between the tissues L1 and L2, for example, impedance. Therefore, an impedance signal is input to the controller 14 from the emitters 44 and 46 through the conductors 54 and 56.
- the stop timing of energy output from the energy source 72 to the emitters 44 and 46 can be automatically controlled.
- the applicator 28 makes the linear member 22 substantially straight when it is disposed inside, and the linear shape when the linear member 22 protrudes from the tip thereof.
- the member 22 includes a tubular body (sheath) 82 that accommodates the protruding portion of the member 22 so as to hold the tissue, and a puncture portion 84 disposed at the distal end of the tubular body 82. That is, the applicator 28 has a puncture portion 84 that can puncture a treatment target at the tip thereof. The puncture portion 84 at the tip of the applicator 28 can puncture the treatment target and can penetrate the treatment target.
- the holding part 32 of the linear member 22 is straightened and accommodated in the tubular body 82 of the applicator 28.
- the connector 58 is connected to the controller 14.
- the endoscope is inserted so that the distal end surface of the insertion portion of the endoscope faces the treatment target in the body cavity.
- the application of the treatment device 12 in a state where the linear member 22 is substantially straight through the treatment instrument insertion channel of the endoscope with the distal end surface of the distal end portion of the insertion portion of the endoscope facing the treatment target in the body cavity.
- the puncture portion 84 of the taper 28 is opposed to the first tissue L1 to be treated.
- the first tissue L1 and the second tissue L2 to be treated are penetrated by the puncture portion 84 of the applicator 28.
- the distal end side coil body 32 a of the holding portion 32 of the linear member 22 is caused to protrude from the distal end (puncture portion 84) of the applicator 28 by the pusher portion 34.
- the temperature of the distal end side coil body 32a of the sandwiching portion 32 of the linear member 22 is increased by, for example, body temperature, and is deformed from a substantially straight state to a tissue sandwiching state.
- the puncture portion 84 is pulled out from the state penetrating the first tissue L1 and the second tissue L2 so as to face the first tissue L1. For this reason, the distal end side coil body 32a is indwelled on the second tissue L2 side.
- the pusher portion 34 causes the proximal end side coil body 32 b of the holding portion 32 of the linear member 22 to protrude from the distal end (puncture portion 84) of the applicator 28.
- the temperature of the proximal end side coil body 32b of the clamping portion 32 of the linear member 22 rises due to, for example, body temperature, and deforms from a substantially straight state to a tissue clamping state. For this reason, the 1st structure
- the first tissue L1 and the second tissue L2 are clamped by the clamping unit 32 and are in close contact with each other.
- the holding portion 32 since the holding portion 32 has a shape memory, the emitter 44a of the first energy emitting portion 24 and the emitter 46a of the second energy emitting portion 26 face each other, and the first energy is released.
- the emitter 44b of the emitter 24 and the emitter 46b of the second energy emitter 26 face each other, and the emitter 44c of the first energy emitter 24 and the emitter 46c of the second energy emitter 26 face each other.
- the emitter 44d of the first energy emitter 24 and the emitter 46d of the second energy emitter 26 face each other.
- the first pedal 16a of the foot switch 16 connected to the controller 14 is depressed and operated.
- the controller 14 controls the energy source 72 and the switching unit 74 so as to appropriately change between the emitter 44 a of the first energy emitter 24 and the emitter 46 a of the second energy emitter 26.
- High frequency energy heat energy
- energy E1 is input to the tissues L1 and L2 between the emitters 44a and 46a, the tissues L1 and L2 are denatured, and the tissues L1 and L2 are joined to each other. That is, the controller 14 controls the switching unit 74 to add energy E1 between the more proximal emitters 44a and 46a, such as between the emitter 44a and the emitter 46b.
- the controller 14 controls the energy source 72 to stop the output of the high frequency energy.
- the controller 14 controls the energy source 72 and the switching unit 74 to add high-frequency energy at an appropriate output between the emitter 44b of the first energy emitter 24 and the emitter 46b of the second energy emitter 26. Then, the tissues L1 and L2 between the emitters 44b and 46b are joined. The high frequency energy is added between the emitters 44b and 46b immediately after the addition of the high frequency energy between the emitters 44a and 46a. In this case, “immediately after” is preferably simultaneously with the end of applying high-frequency energy between the emitters 44a and 46a. Similarly, the controller 14 adds high-frequency energy between the emitters 44c and 46c with an appropriate output immediately after finishing adding the high-frequency energy between the emitters 44b and 46b.
- the controller 14 controls the energy source 72 and the switching unit 74 to sequentially release energy E1 between the emitters 44 and 46 that are close to each other. For this reason, annular joint portions are formed in the tissues L1 and L2, and the tissues L1 and L2 are joined.
- the controller 14 notifies the user that the work of joining the series of tissues L1 and L2 is completed, for example, by voice and / or monitor display.
- the user releases the first pedal 16a.
- the linear member 22 is cut. At this time, it is preferable to cut a portion of the linear member 22 that protrudes from the tip of the applicator 28. For example, it is preferable to cut the vicinity of the boundary between the sandwiching portion 32 and the pusher portion 34. This operation is performed by, for example, another forceps inserted endoscopically.
- the pusher part 34 and the applicator 28 of the linear member 22 are extracted from the channel of the endoscope. For this reason, in the state which joined structure
- the controller 14 controls the switching unit 74 to release energy between the emitters 44a and 46a, between the emitters 44b and 46b, between the emitters 44c and 46c, and between the emitters 44d and 46d.
- the controller 14 controls the switching unit 74 to output energy between the emitters 44 and 46 in the winding direction L.
- the controller 14 controls the switching unit 74 to simultaneously apply energy to the emitters 44 and 46 that are paired like the emitters 44a and 46a (opposing along the axial direction of the central axis C). If supplied, the order of energy output to the emitters 44, 46 may be random.
- the emitters 44a and 44b, the emitters 44b and 44c, the emitters 44c and 44d, and the emitters 44d and 44a of the first energy emitting unit 24 are drawn at appropriate intervals. .
- the emitters 46a and 46b, between the emitters 46b and 46c, between the emitters 46c and 46d, and between the emitters 46d and 46a of the second energy emitting unit 26 are depicted in a state of being separated from each other at appropriate intervals. For this reason, for example, when the tissues L1 and L2 are joined, the joining portion can be a broken-line ring, not a solid-line ring.
- the intervals between the emitters 44 and 46 adjacent to each other along the winding direction (longitudinal direction of the linear member 22) L are reduced (the areas of the emitters 44 and 46 themselves are increased), and the emitters 44 and 46 are disposed.
- the first tissue L1 and the second tissue L2 can be joined to each other by forming a solid annular joint and joining the tissues L1 and L2.
- the first tissue L1 and the second tissue L2 are sandwiched between the distal coil body 32a and the proximal coil body 32b. That is, the first tissue L1 and the second tissue L2 are in close contact with each other.
- the emitter 44 a of the first energy emitter 24 and the emitter 46 a of the second energy emitter 26 face each other, and the emitter 44 b of the first energy emitter 24 and the second energy
- the emitter 46b of the emitter 26 is opposed to the emitter 44c of the first energy emitter 24 and the emitter 46c of the second energy emitter 26 is opposed to the emitter 44d of the first energy emitter 24.
- the emitter 46d of the two-energy emitting unit 26 faces the emitter 46d.
- the controller 14 controls the energy source 72 and the switching unit 74 so as to appropriately change between the emitter 44 a of the first energy emitter 24 and the emitter 46 c of the second energy emitter 26.
- High frequency energy heat energy
- energy E2 is input into the tissues L1 and L2 between the emitters 44a and 46c, and the tissues L1 and L2 are denatured.
- the energy density between the emitters 44a and 46c is highest on the central axis C. That is, the controller 14 controls the switching unit 74 to add energy E2 between the more distal emitters 44a and 46c, such as between the emitter 44a and the emitter 46c.
- the biological information of the tissues L1 and L2 between the emitters 44a and 46c for example, impedance is detected by the emitters 44a and 46c to detect the state of the biological tissue.
- the controller 14 controls the energy source 72 to stop the output of the high frequency energy.
- the impedance threshold in the first mode and the impedance threshold in the second mode may be the same or different.
- the controller 14 controls the energy source 72 and the switching unit 74 to add high-frequency energy at an appropriate output between the emitter 44b of the first energy emitter 24 and the emitter 46d of the second energy emitter 26.
- the tissues L1 and L2 between the emitters 44b and 46d are denatured.
- the high frequency energy is added between the emitters 44b and 46d immediately after the addition of the high frequency energy between the emitters 44a and 46c.
- the controller 14 adds high-frequency energy between the emitters 44c and 46a at an appropriate output immediately after finishing adding the high-frequency energy between the emitters 44b and 46d. Further, immediately after the high frequency energy is added between the emitters 44c and 46a, the high frequency energy is added between the emitters 44d and 46b with an appropriate output.
- the controller 14 controls the energy source 72 and the switching unit 74 to sequentially release the energy E2 between the emitters 44 and 46 that are separated from each other.
- an annular hole H is formed on the central axis C in the tissues L1 and L2, and the periphery of the hole H is joined. Therefore, by using the treatment system 10, it is possible to form the hole H that maintains the state in which the tissues L1 and L2 communicate with each other.
- the controller 14 informs the user that the operation of forming the holes H in the series of tissues L1 and L2 is completed, for example, by voice and / or monitor display.
- the user releases the second pedal 16b.
- the linear member 22 is cut. Thereafter, the pusher portion 34 and the applicator 28 of the linear member 22 are extracted from the channel of the endoscope. For this reason, in the state where the hole H is formed on the central axis C of the site where the tissues L1 and L2 are clamped by the clamping unit 32 and the periphery of the central axis C is joined, the clamping unit 32 of the linear member 22 The tissue L1 and L2 are held in a sandwiched state. Since the clamping part 32 maintains the state which clamped structure
- the controller 14 controls the switching unit 74 to release energy between the emitters 44a and 46c, between the emitters 44b and 46d, between the emitters 44c and 46a, and between the emitters 44d and 46b.
- the treatment device 12 When performing surgical suturing under an endoscope, it is necessary to perform work in a narrow space, so high technology is required.
- the treatment device 12 can be used by being inserted into a channel of an endoscope. And after this treatment device 12 punctures the treatment object with the applicator 28, the front end side coil body 32a of the clamping part 32 of the linear member 22 is protruded, the applicator 28 is pulled in, and the proximal end side of the clamping part 32 It is only necessary to project the coil body 32b and supply energy from the energy source 72 to the discharge portions 24 and 26 disposed on the distal end side coil body 32a and the proximal end side coil body 32b in accordance with the treatment.
- the operation of sandwiching the tissues L1 and L2 can be performed only by appropriately moving the applicator 28 and the linear member 22 in the axial direction of the central axis C. Therefore, when using the treatment device 12 according to this embodiment, it is possible to perform an operation of sandwiching the tissues L1 and L2 with a simple operation.
- an annular joint or hole H is formed in the treatment target. be able to.
- the controller 14 controls the energy source 72 and the switching unit 74 to add energy E1 between the more proximal emitters 44a and 46a, such as between the emitters 44a and 46a. Can be formed.
- the controller 14 controls the energy source 72 and the switching unit 74 to add energy E2 between the more distal emitters 44a and 46c, as in the emitters 44a and 46c, thereby forming a joint.
- a hole H that communicates the tissue L1 side and the tissue L2 side can be formed.
- the treatment system 10 performs a treatment to denature the living tissues L1 and L2 using thermal energy. Therefore, when joining the tissues L1 and L2 to be treated and joining the tissues L1 and L2.
- the working time for forming the hole H can be greatly reduced.
- the hole H is formed inside the tissues while joining the tissues, it is not necessary to simply stop the blood flow and wait for the cells to be necrotized.
- the periphery of the hole H can be joined while forming the hole H in a short time. And the state which the structure
- the treatment device 12 can be used under an endoscope, a minimally invasive state can be maintained when treating a treatment target, and a high bonding force can be achieved earlier with a simple technique. Tissues can be joined together to obtain In addition, depending on the direction of energy input, it is possible to form a hole that joins tissues and maintains a connected state.
- a minimally invasive state when treating a treatment target, a minimally invasive state can be maintained, and the tissues can be connected to each other so as to obtain a high bonding force at an early stage with a simple procedure. Can be joined.
- the emitters 44 a and 44 b, the emitters 44 b and 44 c, the emitters 44 c and 44 d, and the emitters 44 d and 44 a of the first energy emitting unit 24 are separated from each other at appropriate intervals. Painted.
- the emitters 46a and 46b, between the emitters 46b and 46c, between the emitters 46c and 46d, and between the emitters 46d and 46a of the second energy emitting unit 26 are depicted in a state of being separated from each other at appropriate intervals.
- tissue L1 By narrowing the interval between the emitters 44 and 46 adjacent to the winding direction (longitudinal direction of the linear member 22) L and appropriately controlling the output energy between the emitters 44 and 46, the first tissue L1 is obtained. And the 2nd structure
- holes may be formed by simultaneously outputting energy from all of the emitters 44a, 44b, 44c, 44d, 46a, 46b, 46c, and 46d.
- the first mode is described as one treatment operation and the second mode is described as another treatment operation.
- the first mode joining operation and the second operation drilling operation may be performed as a series of treatment operations. Of course it is good.
- a second embodiment will be described with reference to FIG.
- This embodiment is a modification of the first embodiment, and the same members as those described in the first embodiment or members having the same functions are denoted by the same reference numerals as much as possible, and detailed description thereof is omitted.
- the example in which the first energy emitting unit 24 includes the four emitters 44 and the second energy emitting unit 26 includes the four emitters 46 has been described.
- the first energy release portion 24 provided on the distal end side coil body 32 a of the sandwiching portion 32 has five emitters 44 a, 44 b, 44 c, 44 d, 44 e, and sandwiches them.
- the second energy release portion 26 provided on the proximal end side coil body 32b of the portion 32 has five emitters 46a, 46b, 46c, 46d, and 46e. That is, the number of each of the emitters 44 and 46 may be an odd number. In this embodiment, for simplicity of explanation, it is assumed that the emitters 44 and 46 are arranged at the apex of a regular pentagon with the central axis (center of gravity) C as the center.
- the controller 14 appropriately controls the energy source 72 and the switching unit 74, and the emitters facing along the axial direction of the central axis C as described in the first embodiment.
- Energy E1 is emitted to the tissue between the emitters 44 and 46 facing each other in a pair. That is, the controller 14 controls the switching unit 74 to add energy E1 between the more proximal emitters 44a and 46a, such as between the emitter 44a and the emitter 46a.
- the controller 14 controls the switching part 74, for example, discharge
- a junction is formed in
- the controller 14 appropriately controls the energy source 72 and the switching unit 74 to sequentially release energy E2 to the tissue between the emitters 44b and 46d and the tissue between the emitters 44b and 46e.
- energy may be simultaneously released to the tissue between the emitters 44b and 46d and between the emitters 44b and 46e by the current capacity. That is, the controller 14 controls the switching unit 74 to provide energy E2 between the more distal emitters 44b and 46d and between the emitters 44b and 46e, such as between the emitters 44b and 46d and between the emitters 44b and 46e. Is added.
- the emitters 44 and 46 of this embodiment do not face each other so as to intersect the central axis C. For this reason, the direction in which the energy E2 flows between the emitters 44 and 46 described later is in a twisted position with respect to the central axis C. For example, a line segment connecting the emitter 44b and the emitters 46d and 46e (the portion having the highest energy density in the path of energy E2) is in a twisted position with respect to the central axis C.
- the controller 14 When performing the treatment in the second mode, the controller 14 causes the switching unit 74 to cause the emitters 44 and 46 to release energy between the emitter 44a and the emitters 46c and 46d, and between the emitter 44b and the emitters 46d and 46e. Between the emitter 44c and the emitters 46e and 46a, between the emitter 44d and the emitters 46a and 46b, and between the emitter 44e and the emitters 46b and 46c. In other words, the controller 14 appropriately controls the switching unit 74 to select at least one of the plurality of first energy emitters 44 and at least one of the plurality of second energy emitters 46 among the treatment targets. It is possible to release energy to a portion sandwiched between the two.
- the tissue on the central axis C is cauterized and removed, and holes H are formed in the tissues L1 and L2. Further, the tissues L1 and L2 around the hole H are joined.
- the treatment device 12 can be used under an endoscope, so that it is possible to maintain a minimally invasive state when treating a treatment target. Tissues can be joined to each other so that a high joining force can be obtained earlier with a simple procedure. In addition, depending on the direction of energy input, it is possible to form a hole that joins tissues and maintains a connected state.
- the treatment system 10 when treating a treatment target, a minimally invasive state can be maintained, and the tissues can be connected to each other so as to obtain a high bonding force at an early stage with a simple procedure. Can be joined. In addition, depending on the direction of energy input, it is possible to form a hole that joins tissues and maintains a connected state.
- a third embodiment will be described with reference to FIG.
- This embodiment is a modification of the first and second embodiments, and the same members or members having the same functions as those described in the first and second embodiments are given the same reference numerals as much as possible. Detailed description is omitted.
- the first energy release portion 24 provided in the distal end side coil body 32 a of the holding portion 32 has five emitters 44 a, 44 b, 44 c, 44 d, 44 e
- the second energy release portion 26 provided in the proximal end side coil body 32b of the portion 32 has four emitters 46a, 46b, 46c, and 46d. That is, the number of emitters 44 and 46 may not be the same.
- each of the emitters 44 and 46 may be an even number or an odd number.
- each emitter 44 of the first energy emitting unit 24 is disposed at the apex of a regular pentagon with the central axis (center of gravity) C as the center.
- each emitter 46 of the emitter 26 is disposed at the position of a square apex with the center axis C as the center of gravity.
- the controller 14 appropriately controls the energy source 72 and the switching unit 74 to release energy E1 in the order of the tissue between the emitters 46c and 44c and the tissue between the emitters 46c and 44d.
- energy may be simultaneously released to the tissue between the emitters 46c and 44c and between the emitters 46c and 44d by the current capacity.
- the emitters 44 and 46 of this embodiment do not face the central axis C in parallel, but face each other in a substantially along state.
- the direction in which the energy E1 flows between the emitters 44 and 46 to be described later may not be parallel to the central axis C.
- the line segment connecting the emitter 46e and the emitters 44c, 44d, 44e (the portion with the highest energy density in the path of energy E1) is not parallel to the central axis C. That is, the controller 14 controls the switching unit 74 so that the more proximal emitters 44 of the plurality of emitters 44 of the first energy emitting unit 24 and the plurality of emitters 46 of the second energy emitting unit 26, Energy E1 is added between 46.
- the controller 14 uses the switching unit 74 to set the emitters 44 and 46 that release energy as an example, between the emitter 46a and the emitters 44a, 44b, and 44e, Switching is sequentially performed between the emitters 44a, 44b, and 44c, between the emitter 46c and the emitters 44c, 44d, and 44e, and between the emitter 46d and the emitters 44d and 44e. For this reason, even though the direction in which the energy E1 flows between the emitters 44 and 46 is not parallel to the central axis C, a large amount of energy is input substantially parallel to the central axis C. For this reason, similarly to the treatment in the first mode described in the first embodiment, the joint portion is formed in an annular shape.
- the controller 14 appropriately controls the energy source 72 and the switching unit 74 to sequentially release the energy E2 to the tissue between the emitters 46c and 44a and the tissue between the emitters 46c and 44b.
- energy may be simultaneously released to the tissue between the emitters 46c and 44a and between the emitters 46c and 44b by the current capacity.
- the emitters 44 and 46 of this embodiment do not face each other so as to intersect the central axis C.
- the controller 14 controls the switching unit 74 to provide energy E2 between the more distal emitters 46c and 44a and between the emitters 46c and 44b, such as between the emitters 46c and 44a and between the emitters 46c and 44b. Is added.
- the controller 14 controls the switching unit 74 to provide energy E2 between the more distal emitters 46c and 44a and between the emitters 46c and 44b, such as between the emitters 46c and 44a and between the emitters 46c and 44b.
- the controller 14 controls the switching unit 74 to provide energy E2 between the more distal emitters 46c and 44a and between the emitters 46c and 44b, such as between the emitters 46c and 44a and between the emitters 46c and 44b. Is added.
- the tissue on the central axis C is cauterized and removed, and holes H are formed in the tissues L1 and L2. Further, the tissues L1 and L2 around the hole H are joined.
- the treatment device 12 according to this embodiment can be used under an endoscope, so that a minimally invasive state can be maintained when treating a treatment target.
- tissues can be joined to each other so as to obtain a high joining force at an earlier stage with a simple procedure.
- the treatment system 10 according to this embodiment when treating a treatment target, a minimally invasive state can be maintained, and the tissues can be connected to each other so as to obtain a high bonding force at an early stage with a simple procedure. Can be joined.
- the areas of the emitters 44 and 46 may not be the same.
- a shape memory alloy material is used for the sandwiching portion 32 of the linear member 22 and the shape can be deformed between a straight state and a tissue sandwiching state.
- An elastically deformable part such as a coil spring may be disposed in the tubular body 82 of the applicator 28 in a state of being substantially straight from the tissue sandwiching state. Even if the holding part 32 is formed in this way, the structures L1 and L2 can be held as well as the shape memory alloy material, and energy can be released from the first and second energy releasing parts 24 and 26. Can do.
- Item 1 A joining method for joining living tissues endoscopically, Penetrating the living tissue L1, L2 to be treated from one side (tissue L1 side) to the other side (tissue L2 side) by the applicator 28; Discharging the first clamping body 32a of the linear member 22 from the applicator to the other; Pulling the applicator back to the one side, Releasing the second sandwiching body 32b of the linear member 22 from the applicator to the one side, and sandwiching the living tissues L1 and L2 in cooperation with the first sandwiching body; Releasing thermal energy to the living tissue between the first and second sandwiching bodies and joining the living tissues with the thermal energy in a state where the living tissues are sandwiched by the first and second sandwiching bodies; Cutting the proximal end sides of the first and second sandwiching bodies 32a and 32b among the linear members; Pulling out the applicator and pulling out the proximal end from the cut position of the linear member.
- Item IV The method according to Item IV, wherein the thermal energy is released between energy emitters adjacent to each other between the first and second sandwiching bodies.
- Item 3 The method according to Item ⁇ 2, wherein the release position of the heat energy is switched in order, and the joint becomes circular at the end of the treatment.
- Item 4 A hole forming method for forming holes between living tissues endoscopically, Penetrating the living tissue L1, L2 to be treated from one side (tissue L1 side) to the other side (tissue L2 side) by the applicator 28; Discharging the first clamping body 32a of the linear member 22 from the applicator to the other; Pulling the applicator back to the one side, Releasing the second sandwiching body 32b of the linear member 22 from the applicator to the one side, and sandwiching the living tissues L1 and L2 in cooperation with the first sandwiching body; Heat energy is released to the living tissue between the first and second sandwiching bodies, and the living tissues are joined with the thermal energy while the living tissues are sandwiched by the first and second sandwiching bodies, and a hole is formed. thing, Cutting the proximal end sides of the first and second sandwiching bodies 32a and 32b among the linear members; Pulling out the applicator and pulling out the proximal end from the cut position of the linear member.
- Item IV The method according to Item IV, wherein the thermal energy is released between energy emitters spaced apart from each other between the first and second sandwiching bodies.
- Item 6 The method according to Item 5, wherein the release position of the heat energy is sequentially switched, the joint is formed in an annular shape at the end of the treatment, and the hole H is formed inside the annular portion.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Surgical Instruments (AREA)
Abstract
Description
第1実施形態について、図1から図9を用いて説明する。
処置デバイス12は、線状部材22と、第1及び第2エネルギ放出部24,26とを有する。処置デバイス12は、線状部材22、第1及び第2エネルギ放出部24,26を処置対象に案内するアプリケータ(案内具)28を有する。処置デバイス12の線状部材22、第1及び第2エネルギ放出部24,26及びアプリケータ28は、図示しない内視鏡のチャンネルに挿通して用いられることが可能であり、かつ、後述するが、チャンネルに挿通して用いられることが好適である。なお、アプリケータ28は例えば電気絶縁性を有する樹脂材で形成されていることが好適である。
線状部材22の挟持部32は、例えばニッケルチタン合金等の形状記憶合金材で形成されていることが好適である。線状部材22の挟持部32は、例えば熱を加えると略真っ直ぐの状態からバネ性を有するコイル状の組織挟持状態に変形される。形状記憶合金材製の線状部材22は、組成の調整により、例えば体温等、体腔内温度より低い温度(例えば常温)では略真っ直ぐの状態を維持し、体温で組織挟持状態に変形するように形成することができる。また、後述する放出体44a,44b,44c,44d,46a,46b,46c,46dとは別に線状部材22又はアプリケータ28の後述する穿刺部84等にヒータを配置して、ヒータから線状部材22に熱を付加して略真っ直ぐの状態から組織挟持状態に変形させるようにしても良い。もちろん、線状部材22として、弾性変形により略真っ直ぐの状態と組織挟持状態(コイル状態)との間を変形可能であることも好適である。
第1エネルギ放出部24は線状部材22の挟持部32が組織挟持状態に変形された状態で第2エネルギ放出部26に対向する。そして、第1エネルギ放出部24は第2エネルギ放出部26と協働して処置対象を挟持する位置に配設される。言い換えると、第2エネルギ放出部26は、線状部材22の挟持部32が組織挟持状態に変形された状態で、第1エネルギ放出部24と協働して処置対象を挟持する位置に配設される。そして、第2エネルギ放出部26は第1エネルギ放出部24との間にエネルギを放出することにより処置対象を処置する。すなわち、第1及び第2エネルギ放出部24,26を通してこれらの間の処置対象にエネルギを放出することにより処置対象を処置することができる。
第2エネルギ放出部26は、複数(ここでは4つの例について説明する)のエネルギ放出体46a,46b,46c,46d(以下、主に符号46を付す)を有する。各放出体46は、挟持部32が略真っ直ぐの状態で線状部材22の長手方向Lに沿って離間している。言い換えると、各放出体46は、挟持部32の基端側コイル体32bが組織挟持状態(コイル状態)のとき巻き方向Lに沿って適宜の間隔に離間している。そして、各エネルギ放出体46は、互いに対して電気的に絶縁されている。各エネルギ放出体46としては例えば高周波電極やヒータ等を用いることができ、処置対象に熱エネルギを付加することができる。ここでは、エネルギ放出体46として高周波電極を用いる例について説明する。
まず、第1組織L1と第2組織L2とを接合する処置を行う場合(第1モード)について説明する。それに続いて、第1組織L1と第2組織L2とを接合するとともに孔Hを形成して第1組織L1側と第2組織L2側とを連通させる処置を行う場合(第2モード)について説明する。
このため、先端側コイル体32aと基端側コイル体32bとの間で第1組織L1及び第2組織L2を挟持する。すなわち、第1組織L1及び第2組織L2は挟持部32によって挟持されて互いに密着する。このとき、図2に示すように、挟持部32は形状記憶されているので、第1エネルギ放出部24の放出体44aと第2エネルギ放出部26の放出体46aとが対向し、第1エネルギ放出部24の放出体44bと第2エネルギ放出部26の放出体46bとが対向し、第1エネルギ放出部24の放出体44cと第2エネルギ放出部26の放出体46cとが対向し、第1エネルギ放出部24の放出体44dと第2エネルギ放出部26の放出体46dとが対向する。
このとき、放出体44a,46a間の組織L1,L2の生体情報、例えばインピーダンスを放出体44a,46aで検出して、生体組織の状態を検知する。このため、例えばインピーダンスが適宜に設定した閾値に到達したときに、コントローラ14はエネルギ源72を制御して、高周波エネルギの出力を停止させる。
同様に、コントローラ14は、放出体44b,46b間に高周波エネルギを付加するのを終えた直後、適宜の出力で放出体44c,46c間に高周波エネルギを付加する。さらに、放出体44c,46c間に高周波エネルギを付加するのを終えた直後、適宜の出力で放出体44d,46d間に高周波エネルギを付加する。このため、組織L1,L2は放出体44a,46aの間、放出体44b,46b間、放出体44c,46c間、放出体44d,46d間の位置で接合される。
すなわち、コントローラ14は、エネルギ源72及び切替部74を制御して、互いに近接する各放出体44,46間に順にエネルギE1を放出する。このため、組織L1,L2には環状の接合部が形成されて組織L1,L2が接合されている。
このとき、放出体44a,46c間の組織L1,L2の生体情報、例えばインピーダンスを放出体44a,46cで検出して、生体組織の状態を検知する。このため、例えばインピーダンスが適宜に設定した閾値に到達したときに、コントローラ14はエネルギ源72を制御して、高周波エネルギの出力を停止させる。なお、第1モードのインピーダンス閾値と第2モードのインピーダンス閾値は同じであっても、異なっていても良い。
同様に、コントローラ14は、放出体44b,46d間に高周波エネルギを付加するのを終えた直後、適宜の出力で放出体44c,46a間に高周波エネルギを付加する。さらに、放出体44c,46a間に高周波エネルギを付加するのを終えた直後、適宜の出力で放出体44d,46b間に高周波エネルギを付加する。このため、組織L1,L2のうち、挟持部32の中心軸C上のエネルギ密度が高い状態で高周波エネルギが付加される。したがって、中心軸Cに対して交差するように、斜めにエネルギE2を通して真ん中(中心軸C上)を焼灼する。このため、図9に示すように、中心軸C上の生体組織が壊死して除去されて孔Hが形成される。なお、孔Hの周囲はエネルギ密度により環状に接合される。
すなわち、コントローラ14は、エネルギ源72及び切替部74を制御して、互いに離隔する各放出体44,46間に順にエネルギE2を放出する。このため、組織L1,L2のうち、中心軸C上に環状の孔Hが形成され、その孔Hの周囲が接合される。したがって、処置システム10を用いることにより、組織L1,L2同士を連通した状態を維持する孔Hを形成することができる。
その後、内視鏡のチャンネルから、線状部材22のプッシャ部34及びアプリケータ28を抜き取る。このため、組織L1,L2を挟持部32で挟持した部位の中心軸C上に孔Hが形成され、中心軸Cの周囲が接合された状態で、線状部材22のうち、挟持部32が組織L1,L2を挟持した状態で留置される。挟持部32は、組織L1,L2を挟持した状態を維持するので、組織L1,L2同士の接合力を維持することができる。
このように、この処置システム10は、熱エネルギを用いて生体組織L1,L2を変性させる処置を行うので、処置対象の組織L1,L2を接合する場合、及び、組織L1,L2を接合しつつ孔Hを形成する場合の作業時間を大きく短縮することができる。また、組織同士を接合しつつ、その内側に孔Hを形成する場合、単に血流を停止させて細胞が壊死するのを待つ必要がなく、積極的に生体組織に熱エネルギを投入することで、短時間で孔Hを形成しながら、その孔Hの周囲を接合することができる。そして、孔Hにより、組織L1側と組織L2側とが連通した状態を維持することができる。
また、ここでは、放出体44a,44b,44c,44d,46a,46b,46c,46dの対を順に切り替えて環状の接合部を形成する例について説明した。電流容量によっては、全ての放出体44a,44b,44c,44d,46a,46b,46c,46dから同時にエネルギを出力して孔を形成しても良い。
また、第1モードを1つの処置作業とし、第2モードをもう1つの処置作業として説明したが、例えば、第1モードの接合作業と第2作業の孔あけ作業とを一連の処置作業としても良いことはもちろんである。
第1実施形態では、第1エネルギ放出部24に4つの放出体44を有し、第2エネルギ放出部26に4つの放出体46を有する例について説明した。
ここで、この実施形態の放出体44,46は、中心軸Cに交差するように対向しているわけではない。このため、後述する放出体44,46間にエネルギE2が流れる方向は中心軸Cに対してねじれの位置にある。例えば、放出体44bと放出体46d,46eとの間を結ぶ線分(エネルギE2の通り道のうちエネルギ密度が最も高い部分)は、中心軸Cに対してねじれの位置にある。
図11に模式的に示すように、例えば、挟持部32の先端側コイル体32aに設けられた第1エネルギ放出部24が5つの放出体44a,44b,44c,44d,44eを有し、挟持部32の基端側コイル体32bに設けられた第2エネルギ放出部26が4つの放出体46a,46b,46c,46dを有することも好適である。すなわち、放出体44,46の数は同数でなくても良い。また、各放出体44,46の数は偶数であっても奇数であっても良い。
この実施形態では、説明の簡略化のため、第1エネルギ放出部24の各放出体44が中心軸(重心)Cを中心として正五角形の頂点の位置に配置されているものとし、第2エネルギ放出部26の各放出体46が中心軸Cを重心とする正方形の頂点の位置に配置されているものとする。
ここで、この実施形態の放出体44,46は、中心軸Cに平行に対向しているわけではなく、略沿った状態で対向している。このため、後述する放出体44,46間にエネルギE1が流れる方向は中心軸Cに対して平行でなくても良い。例えば、放出体46eと放出体44c,44d,44eとの間を結ぶ線分(エネルギE1の通り道のうちエネルギ密度が最も高い部分)は中心軸Cに対して平行ではない。すなわち、コントローラ14は切替部74を制御して、第1エネルギ放出部24の複数の放出体44と、第2エネルギ放出部26の複数の放出体46との、より近位の放出体44,46間にエネルギE1を付加する。
ここで、この実施形態の放出体44,46は、中心軸Cに交差するように対向しているわけではない。すなわち、コントローラ14は切替部74を制御して、放出体46c,44a間、放出体46c,44b間のように、より遠位の放出体46c,44a間、放出体46c,44b間にエネルギE2を付加する。第2実施形態で説明したように、放出体44,46間にエネルギE2が流れる方向が中心軸Cに対してねじれの位置にある場合でも、中心軸Cの近傍に多くのエネルギが投入されることになるので、中心軸Cの近傍でのエネルギ密度が高くなる。このため、第1実施形態で説明した第2モードの処置と同様に、中心軸C上の組織が焼灼されて除去されて組織L1,L2に孔Hが形成される。また、孔Hの周囲の組織L1,L2は接合されている。
また、上述した実施形態では、線状部材22の挟持部32に形状記憶合金材を用いて略真っ直ぐの状態と組織挟持状態との間を変形可能である例について説明したが、挟持部32をコイルバネのような弾性変形可能な部品を組織挟持状態から略真っ直ぐの状態にしてアプリケータ28の管状体82の内部に配置しても良い。挟持部32がこのように形成されていても、形状記憶合金材と同様に、組織L1,L2を挟持することができるとともに、第1及び第2エネルギ放出部24,26からエネルギを放出することができる。
上述した実施形態によれば、以下のことが言える。
アプリケータ28により処置対象の生体組織L1,L2を一方(組織L1側)から他方(組織L2側)に貫通すること、
前記アプリケータから線状部材22の第1挟持体32aを前記他方に放出すること、
前記アプリケータを前記一方に引き戻すこと、
前記アプリケータから線状部材22の第2挟持体32bを前記一方に放出し、前記第1挟持体と協働して、生体組織L1,L2を挟持すること、
前記第1及び第2挟持体間の生体組織に熱エネルギを放出して第1及び第2挟持体で生体組織同士を挟持した状態で生体組織同士を前記熱エネルギで接合すること、
前記線状部材のうち、前記第1及び第2挟持体32a,32bの基端側を切断すること、
前記アプリケータを引き抜くとともに、前記線状部材のうち切断した位置から基端側を引き抜くこと
を有する、方法。
アプリケータ28により処置対象の生体組織L1,L2を一方(組織L1側)から他方(組織L2側)に貫通すること、
前記アプリケータから線状部材22の第1挟持体32aを前記他方に放出すること、
前記アプリケータを前記一方に引き戻すこと、
前記アプリケータから線状部材22の第2挟持体32bを前記一方に放出し、前記第1挟持体と協働して、生体組織L1,L2を挟持すること、
前記第1及び第2挟持体間の生体組織に熱エネルギを放出して第1及び第2挟持体で生体組織同士を挟持した状態で生体組織同士を前記熱エネルギで接合するとともに孔を形成すること、
前記線状部材のうち、前記第1及び第2挟持体32a,32bの基端側を切断すること、
前記アプリケータを引き抜くとともに、前記線状部材のうち切断した位置から基端側を引き抜くこと
を有する、方法。
Claims (14)
- 略真っ直ぐの状態と組織挟持状態との間を変形可能で、前記組織挟持状態に変形された状態で処置対象を挟持することが可能な線状部材と、
前記線状部材に配設され前記線状部材が前記組織挟持状態に変形された状態で、前記処置対象を挟持する位置に配設される第1エネルギ放出部と、
前記第1エネルギ放出部に離間した状態で前記線状部材に配設され前記線状部材が前記組織挟持状態に変形された状態で、前記第1エネルギ放出部と協働して前記処置対象を挟持する位置に配設され前記第1エネルギ放出部との間にエネルギを放出することにより前記処置対象を処置する第2エネルギ放出部と
を具備する処置デバイス。 - 前記第1及び第2エネルギ放出部は、前記線状部材が前記組織挟持状態に変形された状態で、前記組織挟持状態の中心軸に沿った位置、又は、前記中心軸に略沿った位置に対向して配置される、請求項1に記載の処置デバイス。
- 前記第1及び第2エネルギ放出部は、前記線状部材が前記組織挟持状態に変形された状態で、互いに対して前記組織挟持状態の中心軸に交差する位置に対向して配置され、又は、中心軸に対してねじれの位置にある、請求項1に記載の処置デバイス。
- 前記第1エネルギ放出部は、互いに離間した複数の第1エネルギ放出体を有し、
前記第2エネルギ放出部は、互いに離間した複数の第2エネルギ放出体を有し、
前記処置対象のうち、前記複数の第1エネルギ放出体のうちの少なくとも1つと、前記複数の第2エネルギ放出体のうちの少なくとも1つとの間に挟持された部位にエネルギを放出可能である、請求項1に記載の処置デバイス。 - 前記複数の第1エネルギ放出体のうちの1つに対して、前記複数の第2エネルギ放出体のうちの最も近位のエネルギ放出体との間に挟持された部位にエネルギを放出可能である、請求項4に記載の処置デバイス。
- 前記複数の第1エネルギ放出体のうちの1つに対して、前記複数の第2エネルギ放出体のうちの最も遠位のエネルギ放出体との間に挟持された部位にエネルギを放出可能である、請求項4に記載の処置デバイス。
- 前記複数の第1エネルギ放出体は、互いに電気的に絶縁され、
前記複数の第2エネルギ放出体は、互いに電気的に絶縁されている、請求項4に記載の処置デバイス。 - その内側に配設されたときに前記線状部材を略真っ直ぐの状態にし、前記線状部材がその先端から突出されたときに前記線状部材のうちその突出された部分を組織挟持状態にする案内具をさらに具備する請求項1に記載の処置デバイス。
- 前記案内具は、その先端に、前記処置対象に穿刺可能な穿刺部を有する、請求項8に記載の処置デバイス。
- 前記第1及び第2エネルギ放出部は、高周波電極を有する、請求項1に記載の処置デバイス。
- 前記第1及び第2エネルギ放出部は、ヒータを有する、請求項1に記載の処置デバイス。
- 請求項1に記載の処置デバイスと、
前記処置デバイスの前記第1及び第2エネルギ放出部に適宜のエネルギを供給可能なエネルギ源を有し、前記エネルギ源を制御するコントローラと
を具備する処置システム。 - 前記処置デバイスの前記第1エネルギ放出部は、互いに離間した複数の第1エネルギ放出体を有し、
前記処置デバイスの前記第2エネルギ放出部は、互いに離間した複数の第2エネルギ放出体を有し、
前記コントローラは、前記複数の第1エネルギ放出体のうちの選択された少なくとも1つ、及び、前記複数の第2エネルギ放出体のうちの選択された少なくとも1つにエネルギを放出可能である、請求項12に記載の処置システム。 - 前記処置デバイスの前記第1エネルギ放出部は、互いに離間した複数の第1エネルギ放出体を有し、
前記処置デバイスの前記第2エネルギ放出部は、互いに離間した複数の第2エネルギ放出体を有し、
前記コントローラは、前記線状部材が前記組織挟持状態のとき、前記組織挟持状態の中心軸に沿って、又は、前記組織挟持状態の中心軸に略沿って前記第1エネルギ放出体と前記第2エネルギ放出体との間をエネルギが流れる状態と、前記組織挟持状態の中心軸に交差するように、又は、前記組織挟持状態の中心軸に対してねじれの位置に、前記第1エネルギ放出体と前記第2エネルギ放出体との間をエネルギが流れる状態とに切り替え可能な切替部を有する、請求項12に記載の処置システム。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015537051A JP5945635B2 (ja) | 2014-03-12 | 2015-02-05 | 処置デバイス及び処置システム |
| CN201580009564.4A CN106028972A (zh) | 2014-03-12 | 2015-02-05 | 处理装置及处理系统 |
| EP15761503.0A EP3117779A4 (en) | 2014-03-12 | 2015-02-05 | Treatment device and treatment system |
| US15/260,066 US20160374757A1 (en) | 2014-03-12 | 2016-09-08 | Treatment device and treatment system |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014-048912 | 2014-03-12 | ||
| JP2014048912 | 2014-03-12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/260,066 Continuation US20160374757A1 (en) | 2014-03-12 | 2016-09-08 | Treatment device and treatment system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2015137024A1 true WO2015137024A1 (ja) | 2015-09-17 |
Family
ID=54071476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2015/053269 Ceased WO2015137024A1 (ja) | 2014-03-12 | 2015-02-05 | 処置デバイス及び処置システム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20160374757A1 (ja) |
| EP (1) | EP3117779A4 (ja) |
| JP (1) | JP5945635B2 (ja) |
| CN (1) | CN106028972A (ja) |
| WO (1) | WO2015137024A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190142507A1 (en) * | 2017-11-14 | 2019-05-16 | Spiration Inc. (dba Olympus Respiratory America) | Fistula creation for fluid drainage |
| CN107928783B (zh) * | 2017-12-29 | 2024-09-06 | 山前(珠海)医疗科技有限公司 | 低温消融导管、低温消融操作装置及低温消融设备 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539886A (ja) * | 1999-03-31 | 2002-11-26 | ソプレーン | 骨盤検査のための双極鉗子 |
| JP2009050592A (ja) * | 2007-08-28 | 2009-03-12 | Terumo Corp | Pfo閉鎖デバイス |
| WO2013069436A1 (ja) * | 2011-11-07 | 2013-05-16 | オリンパスメディカルシステムズ株式会社 | インプラント留置装置 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4010758A (en) * | 1975-09-03 | 1977-03-08 | Medtronic, Inc. | Bipolar body tissue electrode |
| US5047027A (en) * | 1990-04-20 | 1991-09-10 | Everest Medical Corporation | Tumor resector |
| US5263493A (en) * | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
| US5443463A (en) * | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Coagulating forceps |
| US5431649A (en) * | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
| US6129724A (en) * | 1993-10-14 | 2000-10-10 | Ep Technologies, Inc. | Systems and methods for forming elongated lesion patterns in body tissue using straight or curvilinear electrode elements |
| US5507743A (en) * | 1993-11-08 | 1996-04-16 | Zomed International | Coiled RF electrode treatment apparatus |
| US5680860A (en) * | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
| US5722401A (en) * | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
| US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
| US6280441B1 (en) * | 1997-12-15 | 2001-08-28 | Sherwood Services Ag | Apparatus and method for RF lesioning |
| IT1315053B1 (it) * | 2000-11-10 | 2003-01-27 | Thermo Med 2000 Kft | Ago-elettrodo con filamento attivo a radiofrequenza |
| US6497704B2 (en) * | 2001-04-04 | 2002-12-24 | Moshe Ein-Gal | Electrosurgical apparatus |
| US6939348B2 (en) * | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
| DE602004020217D1 (de) * | 2003-05-16 | 2009-05-07 | Trod Medical | Medizinisches gerät mit spiralförmiger elektrode |
| US7306595B2 (en) * | 2003-11-18 | 2007-12-11 | Boston Scientific Scimed, Inc. | System and method for tissue ablation |
| EP1713401A2 (en) * | 2004-01-30 | 2006-10-25 | NMT Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
| CA2600275A1 (en) * | 2005-03-02 | 2006-09-08 | Cathrx Ltd | A heat treatment catheter |
| WO2007030433A2 (en) * | 2005-09-06 | 2007-03-15 | Nmt Medical, Inc. | Removable intracardiac rf device |
| WO2007109171A2 (en) * | 2006-03-17 | 2007-09-27 | Microcube, Llc | Devices and methods for creating continuous lesions |
| US7935114B2 (en) * | 2007-02-14 | 2011-05-03 | Olympus Medical Systems Corp. | Curative treatment system, curative treatment device, and treatment method for living tissue using energy |
| DE102009059192A1 (de) * | 2009-12-17 | 2011-06-22 | Aesculap AG, 78532 | Chirurgisches System und Steuerungsverfahren für ein chirurgisches Instrument und Verfahren zum Verbinden von Körpergewebeteilen |
| US9220433B2 (en) * | 2011-06-30 | 2015-12-29 | Biosense Webster (Israel), Ltd. | Catheter with variable arcuate distal section |
| JP6134382B2 (ja) * | 2012-05-11 | 2017-05-24 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | 腎神経変調療法のための多電極カテーテル組立体並びに関連するシステム及び方法 |
| US20140031804A1 (en) * | 2012-07-26 | 2014-01-30 | Medtronic Cryocath Lp | Device and method for ablating tissue |
-
2015
- 2015-02-05 WO PCT/JP2015/053269 patent/WO2015137024A1/ja not_active Ceased
- 2015-02-05 EP EP15761503.0A patent/EP3117779A4/en not_active Withdrawn
- 2015-02-05 JP JP2015537051A patent/JP5945635B2/ja not_active Expired - Fee Related
- 2015-02-05 CN CN201580009564.4A patent/CN106028972A/zh active Pending
-
2016
- 2016-09-08 US US15/260,066 patent/US20160374757A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539886A (ja) * | 1999-03-31 | 2002-11-26 | ソプレーン | 骨盤検査のための双極鉗子 |
| JP2009050592A (ja) * | 2007-08-28 | 2009-03-12 | Terumo Corp | Pfo閉鎖デバイス |
| WO2013069436A1 (ja) * | 2011-11-07 | 2013-05-16 | オリンパスメディカルシステムズ株式会社 | インプラント留置装置 |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP3117779A4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3117779A1 (en) | 2017-01-18 |
| JP5945635B2 (ja) | 2016-07-05 |
| US20160374757A1 (en) | 2016-12-29 |
| EP3117779A4 (en) | 2017-11-15 |
| CN106028972A (zh) | 2016-10-12 |
| JPWO2015137024A1 (ja) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220071694A1 (en) | IRE Ablation Systems and Protocols Using a Basket Catheter | |
| JP4801220B2 (ja) | 治療処置装置および治療用処置具 | |
| JP4729653B2 (ja) | 治療用処置具 | |
| JP5231290B2 (ja) | 治療用処置システムおよび治療用処置具 | |
| US9398932B2 (en) | Clamp based methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed | |
| US7094235B2 (en) | Method and apparatus for tissue ablation | |
| US20060111741A1 (en) | Wound closure device | |
| US11241277B2 (en) | Skin treatment apparatus using RF energy and method for skin treatment using same | |
| CN218484650U (zh) | 消融电极元件 | |
| US20050119653A1 (en) | Surgical methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed | |
| EP3030177A1 (en) | Bipolar surgical instrument | |
| JP2019532779A5 (ja) | ||
| KR20200089760A (ko) | 동시적인 전기수술 봉합 및 절단 | |
| JP5945635B2 (ja) | 処置デバイス及び処置システム | |
| EP4079244A1 (en) | Ire ablation systems and protocols using a basket catheter | |
| US9370344B2 (en) | Method of fusing layers of biological tissue | |
| JP2016150229A (ja) | 内視鏡用カテーテル | |
| JP2009050588A (ja) | Pfo閉鎖デバイス | |
| KR20120138396A (ko) | 쌍꺼풀 시술용 기구 | |
| JP2021142209A (ja) | カテーテルシステム | |
| CN113729924A (zh) | 电极导管及消融设备 | |
| JP2021142210A (ja) | カテーテルシステム及びカテーテルシステムの電圧印加方法 | |
| WO2022071180A1 (ja) | 医療デバイスおよびその制御方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENP | Entry into the national phase |
Ref document number: 2015537051 Country of ref document: JP Kind code of ref document: A |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15761503 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REEP | Request for entry into the european phase |
Ref document number: 2015761503 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2015761503 Country of ref document: EP |